SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 51.59-1.1%Dec 2 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Spekulatius who wrote (4872)10/31/2001 10:56:40 PM
From: Biomaven  Read Replies (1) of 52153
 
Spekulatius,

NPSP vs. NBIX vs. NRGN

Well over the past several months I've reduced my NPSP, sat on my NBIX and bought NRGN. (My holdings are currently NBIX > NRGN > NPSP).

I agree that NRGN is under-appreciated. Not clear it won't just stay that way for a while longer. Maybe people are waiting to see just what stamp Koster, the new CEO, puts on it.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News